Why are the public so positive about colorectal cancer screening?
Tóm tắt
Colorectal cancer (CRC) screening is widely recommended. Earlier research showed that the general public are positive about CRC screening, as too the eligible CRC screening population. Among the eligible CRC screening population this positive perception has been shown to be associated with their perceptions of cancer, preventive health screening and their own health. It is unclear whether these concepts are also associated with the positive perception of the general public. Knowing this can provide insight into the context in which public perception concerning CRC screening is established. The aim of our study was to examine which main perceptions are associated with the public perception concerning CRC screening. An online survey was carried out in a Dutch population sample (adults 18+) among 1679 respondents (response rate was 56%). We assessed the public’s perceptions concerning cancer, preventive health screening, own health, and the government, and examined their possible association with public opinion concerning CRC screening. The public’s positive attitude towards CRC screening is associated with the public’s positive attitude towards preventive health screening in general, their perceived seriousness of cancer, their belief of health being important, and their trust in the government regarding national screening programmes. Trust in the government and perceptions regarding the seriousness of cancer, preventive health screening and the importance of one’s health seem to be important factors influencing how the public view CRC screening. The public are likely to process information about CRC screening in such a way that it confirms their existing beliefs of cancer being serious and preventive screening being positive. This makes it likely that they will notice information about the possible benefits of CRC screening more than information about its possible downsides, which would also contribute to the positive perception of CRC screening.
Tài liệu tham khảo
World Health Organization. Globocan 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012. [http://gco.iarc.fr/today/home]. Accessed 26 Oct 2018.
Integraal Kankercentrum Nederland. Nederlandse Kankerregistratie [Dutch Cancer Registration]. [http://www.cijfersoverkanker.nl] Accessed 2 Feb 2017.
Hardcastle JD, Chamberlain JO, Robinson MH. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348(9040):1472–7.
Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecaloccult-blood test. Lancet. 1996;348(9040):1467–71.
Mandel JS, Bond JH, Church TR. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer control study. N Engl J Med. 1993;328(19):1365–71.
Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993;329(27):1977–81.
Commission of the European Communities. Council Recommendation on Cancer Screening. In., vol. 2003/0093. Brussels: Commission of the European Communities; 2003.
Sung JJ, Lau JY, Young GP. Asia Pacific consensus recommendations for colorectal cancer screening. Gut. 2008;57(8):1166–76.
Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW Jr, Garcia FA, Gillman MW, Harper DM, Kemper AR, Krist AH, et al. Screening for colorectal Cancer: US preventive services task force recommendation statement. Jama. 2016;315(23):2564–75.
MEv L, Toes E, VMCM S, AJv V, Dekker E, Kuipers EJ, et al. Landelijke monitoring bevolkingsonderzoek darmkanker [national monitoring colorectal cancer screening programme] - monitor 2015 - Erasmus MC / NKI-AVL. Bilthoven: Rijksinstituut voor Volksgezondheid en Milieu; 2016.
Cullati S, Charvet-Berard AI, Perneger TV. Cancer screening in a middle-aged general population: factors associated with practices and attitudes. BMC Public Health. 2009;9:118.
Hall NJ, Rubin GP, Dobson C, Weller D, Wardle J, Ritchie M, Rees CJ. Attitudes and beliefs of non-participants in a population-based screening programme for colorectal cancer. Health Expect. 2013;18:1645–57.
Murphy CC, Vernon SW, Haddock NM, Anderson ML, Chubak J, Green BB. Longitudinal predictors of colorectal cancer screening among participants in a randomized controlled trial. Prev Med. 2014;66:123–30.
Smith SK, Simpson JM, Trevena LJ, McCaffery KJ. Factors associated with informed Decisions and participation in bowel Cancer screening among adults with lower education and literacy. Med Decis Mak. 2014;34(6):756–72.
Schwartz LM, Woloshin S, Fowler FJ, Welch HG. Enthusiasm for cancer screening in the United States. J Am Med Assoc. 2004;291(1):71–8.
Waller J, Osborne K, Wardle J. Enthusiasm for cancer screening in Great Britain; a general population study. Br J Cancer. 2015;112:562–6.
McCaffery K, Wardle J, Waller J. Knowledge, attitudes, and behavioral intentions in relation to the early detection of colorectal cancer in the United Kingdom. Prev Med. 2003;36(5):525–35.
Gezondheidsraad [Health Council of the Netherlands]. Bevolkingsonderzoek naar darmkanker. Den Haag: Gezondheidsraad; 2009.
Gray JA, Patnick J, Blanks RG. Maximising benefit and minimising harm of screening. BMJ (Clinical research ed). 2008;336(7624):480–3.
Saquib N, Saquib J, Ioannidis JP. Does screening for disease save lives in asymptomatic adults? Systematic review of meta-analyses and randomized trials. Int J Epidemiol. 2015;44(1):264–77.
Fitzpatrick-Lewis D, Ali MU, Warren R, Kenny M, Sherifali D, Raina P. Screening for colorectal Cancer: a systematic review and meta-analysis. Clin Colorectal Cancer. 2016;15(4):298-13.
Hoffman RM, Lewis CL, Pignone MP, Couper MP, Barry MJ, Elmore JG, Levin CA, Van Hoewyk J, Zikmund-Fisher BJ. Decision-making processes for breast, colorectal, and prostate cancer screening: the DECISIONS survey. Med Decis Making. 2010;30(5 Suppl):53s–64s.
Irwig L, McCaffery K, Salkeld G, Bossuyt P. Informed choice for screening: implications for evaluation. Bmj. 2006;332(7550):1148–50.
Jepson RG, Hewison J, Thompson A, Weller D. Patient perspectives on information and choice in cancer screening: a qualitative study in the UK. Soc Sci Med. 2007;65(5):890–9.
Johansson M, Brodersen J. Informed choice in screening needs more than information. Lancet. 2015;385(9978):1597–9.
Rimer BK, Briss PA, Zeller PK, Chan EC, Woolf SH. Informed decision making: what is its role in cancer screening? Cancer. 2004;101(5 Suppl):1214–28.
Marteau TM, Dormandy E, Michie S. A mesaure of informed choice. Health Expect. 2001;4(2):99–108.
Park HS, Smith SW. Distinctiveness and influence of subjective norms, personal descriptive and injunctive norms, and societal descriptive and injunctive norms on behavioral intent: a case of two behaviors critical to organ donation. Hum Commun Res. 2007;33:194–218.
Mutz DC. Impersonal influence: how perceptions of mass collectives affect political attitudes. New York: Cambridge University Press; 1998.
Fiske ST, Taylor SE. Social cognition 2nd edn. New York: McGraw-Hill; 1991.
Noelle-Neumann E. The spiral of silence: a theory of public opinion. J Commun. 1974;24:43–51.
Soroka S, Maioni A, Martin P. What moves public opinion on health care? Individual experiences, system performance, and media framing. J Health Polit Policy Law. 2013;38(5):893–920.
Bleackley A, Hennessy M, Fishbein M. Public opinion on sex education in US schools. Arch Pediatr Adolesc Med. 2006;160:1151–6.
Nisbet M, Markowitz EM. Understanding public opinion in debates over biomedical research: looking beyond political partisanship to focus on beliefs about science and society. PLoS One. 2014;9(2):e88473.
Ho SS, Brossard D, Scheufele DA. Effects of value predispositions, mass media use, and knowledge on public attitudes toward embryonic stem cell research. Int J Public Opin Res. 2008;20(2):171–92.
van den Bruel A, Jones C, Yang Y, Oke J, Hewitson P. People’s willingness to accept overdetection in cancer screening: population survey. BMJ (Clinical research ed). 2015;350:h980.
Douma LN, Uiters E, Timmermans DR. The Dutch public are positive about the colorectal cancer-screening programme, but is this a well-informed opinion? BMC Public Health. 2016;16(1):1208.
Beydoun HA, Beydoun MA. Predictors of colorectal cancer screening behaviors among average-risk older adults in the United States. Cancer Causes Control. 2008;19(4):339–59.
Glik DC. Risk communication for public health emergencies. Annu Rev Public Health. 2007;28:33–54.
Chong D, Druckman JN. Framing theory. Annu Rev Polit Sci. 2007;10(1):103–26.
Kunda Z: Social cognition: making sense of people: MIT press; 1999.
Clements B. Exploring public opinion on the issue of climate change in Britain. Br Polit. 2012;7(2):183–202.
Smith SK, Kearney P, Trevena L, Barratt A, Nutbeam D, McCaffery KJ. Informed choice in bowel cancer screening: a qualitative study to explore how adults with lower education use decision aids. Health Expect. 2014;17(4):511–22.
Vrinten C, Waller J, von Wagner C, Wardle J. Cancer Fear: Facilitator and Deterrent to Participation in Colorectal Cancer Screening. Cancer Epidemiol Biomarkers Prev. 2015;24(2):400-05.
de Haan MC, de Wijkerslooth TR, Stoop E, Bossuyt P, Fockens P, Thomeer M, Kuipers EJ, Essink-Bot ML, van Leerdam ME, Dekker E, et al. Informed decision-making in colorectal cancer screening using colonoscopy or CT-colonography. Patient Educ Couns. 2013;91(3):318–25.
Gordon NP, Green BB. Factors associated with use and non-use of the fecal immunochemical test (FIT) kit for colorectal Cancer screening in response to a 2012 outreach screening program: a survey study. BMC Public Health. 2015;15:546.
Solmi F, Von Wagner C, Kobayashi LC, Raine R, Wardle J, Morris S. Decomposing socio-economic inequality in colorectal cancer screening uptake in England. Soc Sci Med. 2015;134:76–86.
Wvd W, Timmermans DR, Beaujean DJ, Oudhoff J, van Steenbergen JE. Monitoring the level of government trust, risk perception and intention of the general public to adopt protective measures during the influenza A (H1N1) pandemic in The Netherlands. BMC Public Health. 2011;11:575.
Siegrist M, Cvetokovich G. Perception of hazards: the role of social trust and knowledge. Risk Anal. 2000;20(5):713–9.
Goffman E. Frame analysis: an essay on the Organization of Experience. New York: Harper & Row; 1974.
St Pierre M, Hofinger G, Buerschaper C, Simon R. Information processing and mental models: world views. In: Crisis management in acute care settings human factors and team psychology in a high-stakes environment 2edn. Berlin Heidelberg: Springer International Publishing; 2011. p. 101–19.
Hoffman LH, Glynn CJ, Huge ME, Sietman RB, Thomson T. The role of communication in public opinion processes: understanding the impacts of intrapersonal, media, and social filters. Int J Public Opin Res. 2007;19(3):287–312.
van Dam L, Korfage IJ, Kuipers EJ, Hol L, van Roon AH, Reijerink JC, van Ballegooijen M, van Leerdam ME. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy? Eur J Cancer. 2013;49(10):2321–30.
Weinman J, Petrie KJ, Moss-Morris R, Horne R. The illness perception questionnaire: a new method for assessing illness perceptions. Psychol Health. 1996;11:431–46.
Jacobs LA. Health beliefs of first-degree relatives of individuals with colorectal cancer and participation in health maintenance visits: a population-based survey. Cancer Nurs. 2002;25(4):251–65.
Brewer NT, Chapman GB, Gibbons FX, Gerrard M, McCaul KD, Weinstein ND. Meta-analysis of the relationship between risk perception and health behavior: the example of vaccination. Health Psychol. 2007;26(2):136–45.
Janssen E, van Osch L, de Vries H, Lechner L. Measuring risk perceptions of skin cancer: reliability and validity of different operationalizations. Br J Health Psychol. 2011;16(Pt 1):92–112.
Champion VL, Skinner CS. A breast cancer fear scale: psychometric development. J Health Psychol. 2004;9:753–62.
Lumpkins C, Cupertino P, Young K, Daley C, Yeh H, Greiner K. Racial/ethnic variations in colorectal Cancer screening self-efficacy, fatalism and risk perception in a safety-net clinic population: implications for tailored interventions. J Community Med Health Educ. 2013;3:11284.
Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–83.
Dekker P, de Ridder J, Gude R. Burgerperspectieven [citizen perspectives] 2014/3. Den Haag: Sociaal Cultureel Planbureau; 2014.
CBS [Statistics Netherlands]. MOA Golden Standard. [www.moaweb.nl/services/services/gouden-standaard.html] Accessed 9 Apr 2015.
Hoeppner BB, Kelly JF, Urbanoski KA, Slaymaker V. Comparative utility of a single-item versus multiple-item measure of self-efficacy in predicting relapse among young adults. J Subst Abus Treat. 2011;41(3):305–12.
Diamantopoulos A, Sarstedt M, Fuchs C, Wilczynski P, Kaiser S. Guidelines for choosing between multi-item and single-item scales for construct measurement: a predictive validity perspective. J Acad Mark Sci. 2012;40:434–49.